New User:

-or-
Username:
Password:
Forgot your password?
News Breaks
07:50 EDTAGN
theflyonthewall.com: Allergan Botox usage unlikely to be affected by tax, says William Blair
William Blair believes a tax on Allergan's Botox is unlikely to materially alter usage and points out that around 50% of Botox sales are derived from therapeutic indications not affected by the proposed tax. The firm keeps an Outperform rating on Allergan shares. :theflyonthewall.com



News For AGN From The Last 14 Days
Check below for free stories on AGN the last two weeks.
There are 15 items on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing.
February 4, 2010
21:35 EDTAGN
theflyonthewall.com: Jim Cramer's "Mad Money"
Jim Cramer said, "There's money to be made in this panic." He reminded viewers that no one ever made a dime while panicking, and that just because everything is down, it doesn't mean it should be. Cramer explained Thursday's brutal market action by telling viewers that thanks to the proliferation of global futures markets and ETFs, stocks are now lumped into baskets, and often trade together even though they shouldn't. He said long gone are the days of fundamental securities analysis, which valued companies individually based on their own merits. Instead, today's markets simply trade the S&P500 ETF, and every stock in the average takes the hit. Cramer also explained that this trend is exasperated by large hedge funds, which trade ETFs and futures for the liquidity they offer. He told viewers to remain vigilant and look for bargains. Cramer said companies like Altria (MO), Visa (V) and Cisco (CSCO) didn't deserve the carnage they received Thursday, and that makes them cheap once the panic has passed. RECOVERY PLAY: Investors who owned shares of Botox maker Allergan (AGN) actually made money Thursday, Cramer said. He spoke with chairman and CEO David Pyott. Pyott said that Allergan has weathered the storm very well, thanks in part to strong sales in its eye care business, which accounts for 47% of sales. He said the company has also seen a 18% increase in its dermal filler products. Pyott said investors need to realize the value of the eye care segment and its new product Latisse. He says Allergan's competition in Botox only has low-double-digit market share and he is not concerned. Cramer called Allergan the best medical aesthetics company in the business and said the company is a great recovery play. Next, Cramer interviewed Richard Hill, chairman and CEO of semiconductor equipment maker Novellus (NVLS), a company at the heart of a new boom in technology. Hill said no factory can make chips without the equipment that they provide. He painted a very bullish picture for his industry, saying that he hasn't seen opportunities this good since the 1990s. Today, Hil said, the market drivers are emerging markets, anti-terrorism and gadget loving consumers. Hill dismissed arguments that a slowdown in China will hamper growth. After reporting a 6c a share earnings beat and offering bullish guidance, Cramer said Novellus is an integral part of his Mobile Internet Tsunami and he'd be a buyer. Then, Cramer sat down with Larry O'Donnell, president and CEO of Waste Management (WM). The comapny's natural decomposition process at 1100 of its landfills, is now powering over 400,000 homes in the U.S. The company also has over 400 collection trucks that are running on clean burning natural gas. LIGHTNING ROUND: (Bullish) MCD; C; PG; WN. (Bearish) BKC; MCRS; AIB; CPB; FTR. Reference Link :theflyonthewall.com
14:55 EDTAGN
theflyonthewall.com: Allergan 2010 guidance conservative, says Wells Fargo
After Allergan reported higher than expected Q4 EPS, Wells Fargo thinks the company's growth trends are improving and the firm maintains an Outperform rating on the stock. :theflyonthewall.com
13:58 EDTAGN
theflyonthewall.com: Allergan said it has ability to stay active on acquisition front

Subscribe for More Information
:theflyonthewall.com
12:44 EDTAGN
theflyonthewall.com: Allergan calls active as shares rally 4%
Allergan is recently up $2.28 to $59.15 after a positive report from DealReporter. Cowen upgraded AGN to Outperform from Neutral. AGN discovers and develops specialty pharmaceutical products. February put option implied volatility is at 29, March is at 27; below its 26-week average of 32. Call option volume of 4,586 contracts compares to put volume of 948 contracts according to Track Data, suggesting traders taking positions for upside price movement. :theflyonthewall.com
12:39 EDTAGN
theflyonthewall.com: Allergan upgraded to Outperform from Neutral at Cowen

Subscribe for More Information
:theflyonthewall.com
12:36 EDTAGN
theflyonthewall.com: Allergan has received several takeout offers, reports Dealreporter

Subscribe for More Information
:theflyonthewall.com
09:06 EDTAGN
theflyonthewall.com: Allergan sees Q1 EPS 57c-59c vs. consensus of 68c

Subscribe for More Information
:theflyonthewall.com
07:03 EDTAGN
theflyonthewall.com: Allergan sees FY10 revenue $4.55B-$4.75 vs. consensus of $4.78B

Subscribe for More Information
:theflyonthewall.com
07:02 EDTAGN
theflyonthewall.com: Allergan sees FY10 EPS $3.09-$3.15 vs. consensus of $3.15

Subscribe for More Information
:theflyonthewall.com
06:59 EDTAGN
theflyonthewall.com: Allergan reports Q4 EPS ex-items 78c vs. consensus of 77c

Subscribe for More Information
:theflyonthewall.com

February 3, 2010
16:45 EDTAGN
theflyonthewall.com: On The Fly: U.S. Market Wrap-Up for Wednesday 2/3
The futures were higher in early trading, but weakened prior to the open. The weakness caused the averages to open slightly lower. Almost immediately, however, the indices moved into positive territory. It looked as if the market would put together its first three day winning streak in several weeks. At 10:00 am, the ISM non-manufacturing report came out slightly below expectations, and that was enough to halt the upside momentum of the averages and push them lower. Once in negative territory, the market traded in a fairly narrow range for the remainder of the day…The Dow fell 26.30 to 10,270.55, the S&P lost 6.04 to 1,097.28, and the Nasdaq gained 0.85 to 2,190.91…Among the biggest gainers: Borders Group (BGP) surged 38.3% to $1.30 after noted investor William Ackman commented that the company was unlikely to go bankrupt. Home Diagnostics (HDIX) soared 87.3% to $11.45 after agreeing to be purchased by Nipro Corp. for $11.50 a share…The losers included: Exide Technologies (XIDE) which slumped 23.2% to $6.08 after Wal-Mart (WMT) decided to drop the company as its automotive battery supplier. Ryder System (R) dropped 7.8% to 34.45 after forecasting Q1 EPS that widely missed analysts’ estimates…CURRENCY: The dollar closed 0.68% higher on the yen at 90.98 and 0.51% lower on the euro at 0.7197…COMMODITIES: Crude oil closed down 0.26 to 76.97...Natural gas lost 0.05 to 5.41...Gold was lower by 5.60 to 1,112.40…ECONOMIC DATA: The ADP National Employment Report showed private sector employment decreased by 22,000 in January. January's ADP Report estimates non-farm private employment in the service-providing sector increased by 38,000. Employment in the goods-producing sector declined 60,000, while employment in the manufacturing sector dropped 25,000...January's ISM non-manufacturing index came in at 50.5, slightly below the consensus of 51.0...Challenger's count of layoff announcements jumped to 71,482 in January, well above December's 45,094...The MBA Purchase Index jumped 10.3% in the January 29 week. The EIA Petroleum Status Report came in as follows: Crude inventories 2.32M build vs. consensus of 400K build. Gasoline inventories 1.31M draw vs. consensus of 1.4M build. Distillates 948K draw vs. consensus of 1.15M draw. Tomorrow…Chain Store Sales, Monster Employment Index, Jobless Claims, Productivity and Costs, RBC Cash Index, Factory Orders, and EIA Natural Gas Report are due…Notable companies reporting Thursday before the opening bell include: Allergan (AGN), Avon (AVP), Chicago Mercantile Exchange (CME), Cigna (CI), Cincinnati Financial (CINF), Hospira (HSP), Kellogg (K), MasterCard (MA), Moody’s (MCO), Sara Lee (SLE), Snap-On (SNA), Spectra Energy (SE), and Starwood Hotels & Resorts (HOT). :theflyonthewall.com
15:29 EDTAGN
theflyonthewall.com: Companies reporting Before the Market Open on Thursday, February 4
Notable companies reporting before the opening bell include Allergan (AGN), Chicago Mercantile Exchange (CME), CIGNA (CI), Cincinnati Financial (CINF), Kellogg (K), Hospira (HSP), Moody's (MCO), Sara Lee (SLE), Snap-on (SNA), Spectra Energy (SE), and Starwood Hotels (HOT). :theflyonthewall.com

February 2, 2010
15:08 EDTAGN
theflyonthewall.com: Allergan levels to watch

Subscribe for More Information
:theflyonthewall.com

February 1, 2010
09:05 EDTAGN
theflyonthewall.com: Allergan announces FDA approval of Juvederm XC

Subscribe for More Information
:theflyonthewall.com

January 29, 2010
07:02 EDTAGN
theflyonthewall.com: Spectrum Pharm receives $16M from Asian partners

Subscribe for More Information
:theflyonthewall.com